Found: 21
Select item for more details and to access through your institution.
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update.
- Published in:
- Wiener Klinische Wochenschrift, 2022, v. 134, n. 19/20, p. 683, doi. 10.1007/s00508-022-02082-3
- By:
- Publication type:
- Article
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.
- Published in:
- Wiener Klinische Wochenschrift, 2022, v. 134, n. 1/2, p. 63, doi. 10.1007/s00508-021-01987-9
- By:
- Publication type:
- Article
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone: Analysis of the Austrian head and neck cancer registry of the AGMT.
- Published in:
- Wiener Klinische Wochenschrift, 2021, v. 133, n. 21/22, p. 1131, doi. 10.1007/s00508-021-01939-3
- By:
- Publication type:
- Article
Factor VII deficiency in major artery occlusion stroke.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. 843, doi. 10.1002/ajh.25031
- By:
- Publication type:
- Article
"I was seen by a radiologist, but unfortunately I can't remember the name and I still have questions. What should I do?" Radiologists should give thoughts to improve service professionalism and patient esteem.
- Published in:
- 2020
- By:
- Publication type:
- journal article
HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 5, p. 1115, doi. 10.3390/ijms20051115
- By:
- Publication type:
- Article
miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 2, p. 156, doi. 10.3390/ijms17020156
- By:
- Publication type:
- Article
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042301
- By:
- Publication type:
- Article
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment Landscape for Patients with HER2-Positive Metastatic Breast Cancer: A Review on Emerging Treatment Options.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 10615, doi. 10.2147/CMAR.S235121
- By:
- Publication type:
- Article
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Transcatheter aortic valve implantation in a patient with suspected hereditary von Willebrand disease and severe gastrointestinal bleeding – a case report.
- Published in:
- Scottish Medical Journal, 2019, v. 64, n. 4, p. 142, doi. 10.1177/0036933019862155
- By:
- Publication type:
- Article
Nichtmetastasiertes Pankreaskarzinom : Verbessertes Überleben durch Chemoradiotherapie mit > 40 Gy nach systemischer Behandlung.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 12, p. 5962, doi. 10.1002/cam4.1851
- By:
- Publication type:
- Article
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042301
- By:
- Publication type:
- Article
Dysphagia in the Context of a Serious Systemic Disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1663, doi. 10.3390/jcm9061663
- By:
- Publication type:
- Article
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1014, doi. 10.3390/jcm8071014
- By:
- Publication type:
- Article
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 7, p. 1014, doi. 10.3390/jcm8071014
- By:
- Publication type:
- Article
Overcoming Resistance Against HER2-Targeting Agents in Fifth-Line Therapy: Is There Still a Place for Bevacizumab in HER2(+) Breast Cancer?
- Published in:
- 2014
- By:
- Publication type:
- Journal Article